No material news briefings were available for Gilead Sciences Inc. (GILD) in the period leading to this report's generation date. The prior report dated 2026-08-13 noted a similar absence of discrete corporate announcements, with analysis drawn from verified financial filings and transaction records [Brief - 2026-08-13]. This report reflects data current to 2026-09-11 and is similarly constructed from filing-based sources.
Gilead's trailing twelve-month revenue as of 2026-06-30 stood at approximately $30.46 billion, representing year-over-year growth of 10.18%. Despite this revenue expansion, the company recorded a net loss of $3.24 billion over the same period, producing a net margin of -10.64% and an operating margin of -8.20%. Gross margin remained at 64.95%. Cash on hand was $3.18 billion against total debt of $28.66 billion, yielding a notably leveraged balance sheet. EPS declined 641.67% year-over-year, and no trailing P/E ratio was calculable given the net loss position [SEC 10-Q - GILD - 2026-06-30].
Insider activity over the past 30 days comprised 24 transactions with a net selling direction, aggregating a net disposal value of approximately $9.90 million [SEC Form 4 - GILD - 2026-09]. On the institutional side, four significant managers initiated new positions in GILD during the most recent reporting period: Citadel (Ken Griffin), Millennium (Izzy Englander), AQR Capital (Cliff Asness), and Bridgewater (Ray Dalio) each opened new holdings [SEC 13F - Citadel - Q2 2026; SEC 13F - Millennium - Q2 2026; SEC 13F - AQR Capital - Q2 2026; SEC 13F - Bridgewater - Q2 2026].
The prevailing macroeconomic backdrop features a 10-year US Treasury yield of 4.83% and a 2-year yield of 4.39%, producing a normal yield curve spread of 44 basis points [FRED DGS10; FRED DGS2]. This rate environment is relevant context for a company carrying $28.66 billion in total debt, as borrowing costs and debt refinancing conditions remain a structural consideration in the current period.
This report was triggered by concurrent insider selling activity totalling nearly $9.90 million in net disposals and the simultaneous opening of new institutional positions by four distinct major asset managers, representing material changes in both internal and external ownership dynamics for the instrument.